Skip to main content
. 2022 May 8;14(5):1013. doi: 10.3390/pharmaceutics14051013

Figure 3.

Figure 3

Protein-mediated shielding of Ag NP cytotoxicity. Affibody ZHER2:342 cell labeling. (a): MTT assay results of the SKOV3-1ip and CHO cells viability (%) depending on the concentration of unmodified Ag NPs and BSA-modified Ag-BSA NPs in the medium (µg/mL). (b): Confocal microscopy of HER2-overexpressing SKOV3-1ip and HER2-negative CHO cells labeled with ZHER2:342-FITC. (c): Flow cytometry histograms of SKOV3-1ip and CHO cells showing the cell interaction with ZHER2:342-FITC. Green—cell autofluorescence, blue—cells labeled with affibody.